Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
Clinical trial NCT05640245 · COMPLETED
Trial details
- NCT number
- NCT05640245
- Sponsor
- MoonLake Immunotherapeutics AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2023-09-05
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.